12:00 AM
Oct 25, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

dOTC (BCH-10652): Phase II/III trials update

BioChem Pharma Inc. (BCHE; TSE:BCH), Laval, Quebec
Product: dOTC (BCH-10652)
Business: Infectious diseases
Therapeutic category: Viral replication
Target: HIV reverse...

Read the full 80 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >